DAPASUG-SM-500 - Dapagliflozin 10mg + Sitagliptin 100mg + Metformin (ER) 500mg | Intralife Pharmaceuticals
DIASAGE
Premium

DAPASUG-SM-500

MRP: 2,850

Packaging: 10x10

Pack Type: tablet

Composition:

Dapagliflozin 10mg + Sitagliptin 100mg + Metformin (ER) 500mg

Indication:

Treatment of Type 2 Diabetes mellitus

Description:

Dapagliflozin 10 mg + Sitagliptin 100 mg + Metformin Hydrochloride (Extended Release) 500 mg** is a triple combination oral antidiabetic medication used for the effective management of Type 2 Diabetes Mellitus in adults.

This fixed-dose formulation combines three complementary mechanisms of action:

  • Dapagliflozin (10 mg) – An SGLT2 inhibitor that reduces blood glucose by promoting glucose excretion through urine.

  • Sitagliptin (100 mg) – A DPP-4 inhibitor that increases insulin secretion and reduces glucagon release post-meals.

  • Metformin ER (500 mg) – A biguanide that reduces hepatic glucose production and improves insulin sensitivity with extended-release benefits for better GI tolerance.

This combination is typically prescribed to patients who do not achieve adequate glycemic control with dual therapy. It also offers added benefits like weight reduction, cardiovascular and renal protection, and low risk of hypoglycemia.

Tags:

Type 2 Diabetes Oral Antidiabetics Combination Therapy Extended Release SGLT2 + DPP4 Inhibitor
  • Triple mechanism improves glycemic control effectively
  • Lower HbA1c and fasting/postprandial blood sugar levels
  • Aids in weight loss and blood pressure control
  • Reduced risk of hypoglycemia compared to sulfonylureas
  • Cardiovascular and renal protective effects

Usage Information

Dosage

Recommended Dose: One tablet once daily with meals Take at the same time each day Do not crush or chew – swallow whole Ensure adequate hydration Follow your physician’s instructions carefully

Side Effects

Genital or urinary tract infections (Dapagliflozin) Headache, nausea, diarrhea (Metformin) Nasopharyngitis, upper respiratory tract infection (Sitagliptin) Dehydration or low blood pressure Rare: Lactic acidosis, diabetic ketoacidosis

Contraindications

Hypersensitivity to any active ingredient Type 1 Diabetes or diabetic ketoacidosis Severe renal impairment (eGFR <30 mL/min/1.73m²) Liver dysfunction or history of lactic acidosis Pregnancy and lactation (unless advised by doctor) Alcohol abuse or conditions causing hypoxia

Availability

Dapagliflozin Sitagliptin Metformin 500 mg Triple oral therapy for diabetes Type 2 Diabetes treatment tablets Extended release Metformin combination SGLT2 DPP4 inhibitor combo Oral hypoglycemic triple combo Sitagliptin 100mg tablet Blood sugar lowering medicine Advanced diabetes medication Diabetes combo tablet

Triple combo for Type 2 Diabetes: Dapagliflozin + Sitagliptin | Intralife Pharmaceuticals | Intralife